- Home
- JANX vs PCH Comparison
JANX vs PCH Comparison
Compare JANX & PCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- PCH
- Stock Information
- Founded
- JANX 2017
- PCH 1903
- Country
- JANX United States
- PCH United States
- Employees
- JANX N/A
- PCH N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- PCH Real Estate Investment Trusts
- Sector
- JANX Health Care
- PCH Real Estate
- Exchange
- JANX Nasdaq
- PCH Nasdaq
- Market Cap
- JANX 2.2B
- PCH N/A
- IPO Year
- JANX 2021
- PCH N/A
- Fundamental
- Price
- JANX $26.99
- PCH $42.53
- Analyst Decision
- JANX Strong Buy
- PCH Strong Buy
- Analyst Count
- JANX 8
- PCH 7
- Target Price
- JANX $91.25
- PCH $48.57
- AVG Volume (30 Days)
- JANX 767.1K
- PCH 440.8K
- Earning Date
- JANX 05-06-2025
- PCH 04-28-2025
- Dividend Yield
- JANX N/A
- PCH 4.20%
- EPS Growth
- JANX N/A
- PCH N/A
- EPS
- JANX N/A
- PCH 0.28
- Revenue
- JANX $10,588,000.00
- PCH $1,062,076,000.00
- Revenue This Year
- JANX N/A
- PCH $1.97
- Revenue Next Year
- JANX $289.47
- PCH $6.19
- P/E Ratio
- JANX N/A
- PCH $155.31
- Revenue Growth
- JANX 30.99
- PCH 3.71
- 52 Week Low
- JANX $25.77
- PCH $37.06
- 52 Week High
- JANX $71.71
- PCH $48.12
- Technical
- Relative Strength Index (RSI)
- JANX 33.98
- PCH 34.79
- Support Level
- JANX $29.77
- PCH $44.34
- Resistance Level
- JANX $28.83
- PCH $45.23
- Average True Range (ATR)
- JANX 1.51
- PCH 1.03
- MACD
- JANX -0.01
- PCH -0.23
- Stochastic Oscillator
- JANX 19.58
- PCH 1.22
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.